DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
-4.5%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$33.8B
AUM Growth
-$562M
(-1.6%)
Cap. Flow
+$876M
Cap. Flow
% of AUM
2.59%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
1,460
New
97
Increased
616
Reduced
423
Closed
88
Top Buys
| 1 |
NVIDIA
NVDA
|
+$117M |
| 2 |
L3Harris
LHX
|
+$81.2M |
| 3 |
PNC Financial Services
PNC
|
+$70.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$69.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$68.1M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$71M |
| 2 |
Linde
LIN
|
+$51.8M |
| 3 |
Amazon
AMZN
|
+$42.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$37M |
| 5 |
Encompass Health
EHC
|
+$35.8M |
Sector Composition
| 1 | Technology | 24.13% |
| 2 | Healthcare | 19.65% |
| 3 | Financials | 10.78% |
| 4 | Industrials | 9.28% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
nVent Electric
NVT
$14.6B
| $883K | ﹤0.01% |
27,689
| – | – |
|
902
Liberty Global Class C
LBTYK
$4.04B
| $881K | ﹤0.01% |
53,239
-12,317
| -19% | -$204K |
|
903
Erie Indemnity
ERIE
$17.4B
| $880K | ﹤0.01% |
4,048
+44
| +1% | +$9.57K |
|
904
Bath & Body Works
BBWI
$5.84B
| $879K | ﹤0.01% |
26,448
-5,707
| -18% | -$190K |
|
905
Lucid Motors
LCID
$5.88B
| $879K | ﹤0.01% |
6,173
+1,762
| +40% | +$251K |
|
906
Coinbase
COIN
$80.3B
| $878K | ﹤0.01% |
14,180
-796
| -5% | -$49.3K |
|
907
Twist Bioscience
TWST
$1.5B
| $877K | ﹤0.01% |
25,000
+11,450
| +85% | +$402K |
|
908
dLocal
DLO
$3.98B
| $874K | ﹤0.01% |
42,000
-26,900
| -39% | -$560K |
|
909
Group 1 Automotive
GPI
$6.13B
| $874K | ﹤0.01% |
+6,200
| New | +$874K |
|
|
SAGE
910
DELISTED
Sage Therapeutics
SAGE
| $868K | ﹤0.01% |
22,220
| – | – |
|
911
Huntington Ingalls Industries
HII
$10.4B
| $859K | ﹤0.01% |
3,901
+648
| +20% | +$143K |
|
912
AbCellera Biologics
ABCL
$1.23B
| $850K | ﹤0.01% |
87,000
| – | – |
|
913
PG&E
PCG
$32.7B
| $850K | ﹤0.01% |
70,005
+4,411
| +7% | +$53.6K |
|
914
Ligand Pharmaceuticals
LGND
$3.22B
| $847K | ﹤0.01% |
16,030
+8,752
| +120% | +$462K |
|
915
Enterprise Products Partners
EPD
$68.6B
| $843K | ﹤0.01% |
35,000
| – | – |
|
916
Brookfield Renewable
BEPC
$6.05B
| $838K | ﹤0.01% |
25,263
+21,578
| +586% | +$716K |
|
917
Cousins Properties
CUZ
$4.87B
| $837K | ﹤0.01% |
36,527
-502
| -1% | -$11.5K |
|
918
Vir Biotechnology
VIR
$707M
| $832K | ﹤0.01% |
43,100
| – | – |
|
|
RXDX
919
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $832K | ﹤0.01% |
14,300
| – | – |
|
920
The Ensign Group
ENSG
$9.72B
| $831K | ﹤0.01% |
10,475
+475
| +5% | +$37.7K |
|
921
Prothena Corp
PRTA
$439M
| $830K | ﹤0.01% |
14,000
| – | – |
|
922
Nu Skin
NUS
$566M
| $829K | ﹤0.01% |
24,834
-3,066
| -11% | -$102K |
|
923
Nexstar Media Group
NXST
$6.21B
| $828K | ﹤0.01% |
5,004
-112
| -2% | -$18.5K |
|
924
Jackson Financial
JXN
$6.72B
| $824K | ﹤0.01% |
29,800
-7,152
| -19% | -$198K |
|
|
ALBO
925
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $823K | ﹤0.01% |
45,000
+10,000
| +29% | +$183K |
|